Kyntra Bio Inc (KYNB) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Kyntra Bio Inc   (NASDAQ: KYNB)

Kyntra Bio Inc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

KYNB Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q1 MRQ) -9.84 % 70.86 % 67.33 % 46.14 %
Gross Margin (Q1 TTM) 25.72 % 71.39 % 67.68 % 46.36 %
Gross Profit Margin 5 Yr. Avg. 81.24 % 67.81 % 65.55 % 48.95 %
EBITDA Margin (Q1 MRQ) -369.66 % 21.18 % 17.71 % 20.42 %
EBITDA Margin (Q1 TTM) -611.59 % 25.13 % 20.13 % 20.07 %
EBITDA Margin 5 Yr. Avg. --340.21 % 31.44 % 23.67 % 23.01 %
Operating Margin (Q1 MRQ) -369.66 % 17.04 % 16.13 % 16.03 %
Operating Margin (Q1 TTM) -420.5 % 20.45 % 17.54 % 16.33 %
Operating Margin 5 Yr. Avg. --349.54 % 15.37 % 14.33 % 19.26 %
Pre-Tax Profit Margin (Q1 MRQ) -404.82 % 13.42 % 10.37 % 13.96 %
Pre-Tax Profit Margin (Q1 TTM) -761.7 % 16.68 % 12.43 % 13.1 %
Pre-Tax Profit Margin 5 Yr. Avg. - 12.98 % 10.37 % 13.52 %
Net Margin (Q1 MRQ) -406.58 % 9.91 % 7.68 % 11.41 %
Net Margin (Q1 TTM) 2199.42 % 13.16 % 9.62 % 10.77 %
Net Margin 5 Yr. Avg. 432.75 % 5.79 % 6.08 % 10.8 %



Business Segment Profit Margin
 
Drug Product Revenue Net
  Explore Drug Product Revenue Net Segment  -
Drug Product Revenue Net Astellas Agreement
  Explore Drug Product Revenue Net Astellas Agreement Segment  -
Drug Product Revenue Net Astellas Agreement Japan
  Explore Drug Product Revenue Net Astellas Agreement Japan Segment  -
Drug Product Revenue Net Astellas Agreement Europe
  Explore Drug Product Revenue Net Astellas Agreement Europe Segment  -
Europe Astellas Europe Agreement
  Explore Europe Astellas Europe Agreement Segment  -
Drug Product Revenue Net Europe Astellas Agreement
  Explore Drug Product Revenue Net Europe Astellas Agreement Segment  -
Drug Product Revenue Net Japan Astellas Agreement
  Explore Drug Product Revenue Net Japan Astellas Agreement Segment  -
Drug Product Revenue Net API Shipment
  Explore Drug Product Revenue Net API Shipment Segment  -
Bulk Drug Product Astellas Europe Agreement
  Explore Bulk Drug Product Astellas Europe Agreement Segment  -
Bulk Drug Product Europe Astellas Europe Agreement
  Explore Bulk Drug Product Europe Astellas Europe Agreement Segment  -
Bulk Drug Product Europe Astellas Europe Agreement Royalty Revenue
  Explore Bulk Drug Product Europe Astellas Europe Agreement Royalty Revenue Segment  -
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q1 MRQ) -371.51 % -0.01 % 0.22 % 1.39 %
Free Cash Flow Margin (Q1 TTM) -288.09 % 17.47 % 13.66 % 9.06 %
Free Cash Flow Margin 5 Yr. Avg. - 19.28 % 14.86 % 15.58 %
Net Cash Flow Margin (Q1 MRQ) -290.93 % 0.02 % -0.02 % 0.13 %
Net Cash Flow Margin (Q1 TTM) -74.39 % -0.36 % -0.04 % 1.84 %
Net Cash Flow Margin 5 Yr. Avg. - 4.39 % 3.18 % 6.44 %
Effective Tax Rate (Q1 MRQ) - 25.94 % 25.81 % 18.81 %
Effective Tax Rate (Q1 TTM) 0.16 % 21.36 % 23.39 % 19.42 %
Effective Tax Rate 5 Yr. Avg. - 15.08 % 20.51 % 19.76 %
Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.